BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 8214004)

  • 41. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma.
    Fangazio M; Ladewig E; Gomez K; Garcia-Ibanez L; Kumar R; Teruya-Feldstein J; Rossi D; Filip I; Pan-Hammarström Q; Inghirami G; Boldorini R; Ott G; Staiger AM; Chapuy B; Gaidano G; Bhagat G; Basso K; Rabadan R; Pasqualucci L; Dalla-Favera R
    Proc Natl Acad Sci U S A; 2021 Jun; 118(22):. PubMed ID: 34050029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis.
    Haas GG; D'Cruz OJ; De Bault LE
    Am J Reprod Immunol Microbiol; 1988 Oct; 18(2):47-51. PubMed ID: 2467568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
    Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.
    Higashi M; Tokuhira M; Fujino S; Yamashita T; Abe K; Arai E; Kizaki M; Tamaru J
    Leuk Lymphoma; 2016; 57(1):161-6. PubMed ID: 25860238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of major histocompatibility antigens in human chronic pancreatitis.
    Jalleh RP; Gilbertson JA; Williamson RC; Slater SD; Foster CS
    Gut; 1993 Oct; 34(10):1452-7. PubMed ID: 8244120
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.
    Tooyama I; Kimura H; Akiyama H; McGeer PL
    Brain Res; 1990 Jul; 523(2):273-80. PubMed ID: 2400911
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
    De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
    J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunohistochemical findings in otosclerotic lesions].
    Altermatt HJ; Gerber HA; Gaeng D; Müller C; Arnold W
    HNO; 1992 Dec; 40(12):476-9. PubMed ID: 1493967
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Large cell lymphomas: effect of histologic groups on the prognosis. Study of 210 cases treated with the same therapeutic protocols].
    Dumont J; Charpy-Validire P; Raphael M; Tulliez M; Le Doussal V; Barge J; Mosseri V
    Arch Anat Cytol Pathol; 1992; 40(2-3):110-5. PubMed ID: 1449259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.
    Möller P; Lämmler B; Herrmann B; Otto HF; Moldenhauer G; Momburg F
    Immunology; 1986 Nov; 59(3):411-7. PubMed ID: 3491784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ontogeny of the MHC antigens on human trophoblast cells during the first trimester of pregnancy.
    Montgomery B; Lala PK
    J Immunol; 1983 Nov; 131(5):2348-55. PubMed ID: 6415163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Expression of HLA class II antigen-associated invariant chain on renal cell cancer].
    Saito T; Tomita Y; Kimura M; Nishiyama T; Sato S
    Nihon Hinyokika Gakkai Zasshi; 1993 Jun; 84(6):1036-40. PubMed ID: 8345720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The distribution of MHC class I and II antigens on bronchial epithelium.
    Glanville AR; Tazelaar HD; Theodore J; Imoto E; Rouse RV; Baldwin JC; Robin ED
    Am Rev Respir Dis; 1989 Feb; 139(2):330-4. PubMed ID: 2464294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer.
    Nijman HW; van Diest PJ; Poort-Keesom RJ; von Mensdorff-Pouilly S; Verstraeten RA; Kummer A; Meijer CJ; Melief CJ; Hilgers J; Kenemans P
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):114-20. PubMed ID: 11134836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
    Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
    Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibody analysis of major histocompatibility complex expression in human meningiomas.
    Becker I; Roggendorf W
    J Neuroimmunol; 1989 Dec; 25(2-3):161-7. PubMed ID: 2584394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification.
    Diebold J; Anderson JR; Armitage JO; Connors JM; Maclennan KA; Müller-Hermelink HK; Nathwani BN; Ullrich F; Weisenburger DD
    Leuk Lymphoma; 2002 Jan; 43(1):97-104. PubMed ID: 11908742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.